Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Hepatitis C seroconversions in HIV infection across Europe : which regions and patient groups are affected? / Boesecke, Christoph; Grint, Daniel; Soriano, Vincent; Lundgren, Jens D; d'Arminio Monforte, Antonella; Mitsura, Victor M; Chentsova, Nelly; Hadziosmanovic, Vesnadarjan; Kirk, Ole; Mocroft, Amanda; Peters, Lars; Rockstroh, Jürgen K; EuroSIDA in EuroCoord.
In: Liver International, Vol. 35, No. 11, 11.2015, p. 2384-91.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Hepatitis C seroconversions in HIV infection across Europe
T2 - which regions and patient groups are affected?
AU - Boesecke, Christoph
AU - Grint, Daniel
AU - Soriano, Vincent
AU - Lundgren, Jens D
AU - d'Arminio Monforte, Antonella
AU - Mitsura, Victor M
AU - Chentsova, Nelly
AU - Hadziosmanovic, Vesnadarjan
AU - Kirk, Ole
AU - Mocroft, Amanda
AU - Peters, Lars
AU - Rockstroh, Jürgen K
AU - EuroSIDA in EuroCoord
N1 - © 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2015/11
Y1 - 2015/11
N2 - BACKGROUND & AIMS: In the last decade, several outbreaks of sexually acquired acute hepatitis C (HCV) infection have been described in HIV-positive men who have sex with men (MSM). The aims of this study were to determine whether there has been an increase in the number of acute HCV infections in different parts of Europe.METHODS: HCV seroconversion was defined as an HCV-antibody test change from negative to positive within the observation period in EuroSIDA. Binomial regression was performed to determine factors associated with being tested for HCV and HCV seroconversion.RESULTS: A total of 223 HCV seroconversions were observed from 16,188 tests [1.38% (95%CI 1.20-1.56)] among 5736 patients between 2002 and 2013. Overall the odds of acquiring HCV infection increased by 4% per year (OR 1.04 [95%CI 0.99-1.09]; P = 0.10). Overall 63.2% (141/223) of all seroconversions were seen among MSM. Similar patterns were observed across all European regions (P = 0.69, test for interaction) and HIV transmission risks groups (P = 0.69, test for interaction). In multivariate analysis, North, South and East Europe had higher odds of HCV seroconversion compared with Western Europe [OR 1.90 (1.28-2.81), 1.55 (0.99-2.45) and 1.86 (1.21-2.84); P = 0.0014, P = 0.058 and P = 0.0044 respectively].CONCLUSIONS: Within EuroSIDA a significant increase in HCV seroconversions can be observed after accounting for increased levels of testing for HCV in recent years. This highlights the need for increased HCV prevention efforts among HIV-positive persons in Europe.
AB - BACKGROUND & AIMS: In the last decade, several outbreaks of sexually acquired acute hepatitis C (HCV) infection have been described in HIV-positive men who have sex with men (MSM). The aims of this study were to determine whether there has been an increase in the number of acute HCV infections in different parts of Europe.METHODS: HCV seroconversion was defined as an HCV-antibody test change from negative to positive within the observation period in EuroSIDA. Binomial regression was performed to determine factors associated with being tested for HCV and HCV seroconversion.RESULTS: A total of 223 HCV seroconversions were observed from 16,188 tests [1.38% (95%CI 1.20-1.56)] among 5736 patients between 2002 and 2013. Overall the odds of acquiring HCV infection increased by 4% per year (OR 1.04 [95%CI 0.99-1.09]; P = 0.10). Overall 63.2% (141/223) of all seroconversions were seen among MSM. Similar patterns were observed across all European regions (P = 0.69, test for interaction) and HIV transmission risks groups (P = 0.69, test for interaction). In multivariate analysis, North, South and East Europe had higher odds of HCV seroconversion compared with Western Europe [OR 1.90 (1.28-2.81), 1.55 (0.99-2.45) and 1.86 (1.21-2.84); P = 0.0014, P = 0.058 and P = 0.0044 respectively].CONCLUSIONS: Within EuroSIDA a significant increase in HCV seroconversions can be observed after accounting for increased levels of testing for HCV in recent years. This highlights the need for increased HCV prevention efforts among HIV-positive persons in Europe.
U2 - 10.1111/liv.12848
DO - 10.1111/liv.12848
M3 - Journal article
C2 - 25875966
VL - 35
SP - 2384
EP - 2391
JO - Liver International
JF - Liver International
SN - 1478-3223
IS - 11
ER -
ID: 156368446